- Home
- SCS vs CLDX Comparison
SCS vs CLDX Comparison
Compare SCS & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCS
- CLDX
- Stock Information
- Founded
- SCS 1912
- CLDX N/A
- Country
- SCS United States
- CLDX United States
- Employees
- SCS N/A
- CLDX N/A
- Industry
- SCS Office Equipment/Supplies/Services
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SCS Consumer Discretionary
- CLDX Health Care
- Exchange
- SCS Nasdaq
- CLDX Nasdaq
- Market Cap
- SCS 1.2B
- CLDX 1.2B
- IPO Year
- SCS 1998
- CLDX 2008
- Fundamental
- Price
- SCS $9.77
- CLDX $19.51
- Analyst Decision
- SCS Strong Buy
- CLDX Buy
- Analyst Count
- SCS 2
- CLDX 8
- Target Price
- SCS $17.00
- CLDX $54.29
- AVG Volume (30 Days)
- SCS 961.4K
- CLDX 856.2K
- Earning Date
- SCS 03-26-2025
- CLDX 05-05-2025
- Dividend Yield
- SCS 4.13%
- CLDX N/A
- EPS Growth
- SCS 50.00
- CLDX N/A
- EPS
- SCS 1.02
- CLDX N/A
- Revenue
- SCS $3,166,000,000.00
- CLDX $7,020,000.00
- Revenue This Year
- SCS $4.67
- CLDX N/A
- Revenue Next Year
- SCS $3.62
- CLDX N/A
- P/E Ratio
- SCS $9.49
- CLDX N/A
- Revenue Growth
- SCS 0.20
- CLDX 1.99
- 52 Week Low
- SCS $9.32
- CLDX $14.40
- 52 Week High
- SCS $14.74
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- SCS 39.39
- CLDX 54.30
- Support Level
- SCS $9.32
- CLDX $17.45
- Resistance Level
- SCS $10.01
- CLDX $20.36
- Average True Range (ATR)
- SCS 0.48
- CLDX 1.21
- MACD
- SCS -0.03
- CLDX 0.44
- Stochastic Oscillator
- SCS 26.47
- CLDX 81.21
About SCS Steelcase Inc.
Steelcase Inc is a furniture company based in the United States. Its brands such as Steelcase, AMQ, Coalesse, Designtex, and others offer a portfolio of furniture and architectural products and services designed to help customers create workplaces. It markets its products and services to businesses and organizations predominantly through a network of dealers and also sells to consumers in markets around the world through web-based and retail distribution channels. The company's reportable segments include the Americas which generates key revenue, and International.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.